Cargando…

Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma

Proton fields delivered by the active scanning technique can be interfered with the intrafractional motion. This in-silico study seeks to mitigate the dosimetric impacts of motion artifacts, especially its interplay with the time-modulated dose delivery. Here four-dimensional (4d) robust optimizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Siregar, Hilda, Bäumer, Christian, Blanck, Oliver, Chan, Mark, Engwall, Erik, Plaude, Sandija, Spaan, Bernhard, Timmermann, Beate, Wulff, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948857/
https://www.ncbi.nlm.nih.gov/pubmed/33131995
http://dx.doi.org/10.1016/j.zemedi.2020.08.001
_version_ 1784892868485185536
author Siregar, Hilda
Bäumer, Christian
Blanck, Oliver
Chan, Mark
Engwall, Erik
Plaude, Sandija
Spaan, Bernhard
Timmermann, Beate
Wulff, Jörg
author_facet Siregar, Hilda
Bäumer, Christian
Blanck, Oliver
Chan, Mark
Engwall, Erik
Plaude, Sandija
Spaan, Bernhard
Timmermann, Beate
Wulff, Jörg
author_sort Siregar, Hilda
collection PubMed
description Proton fields delivered by the active scanning technique can be interfered with the intrafractional motion. This in-silico study seeks to mitigate the dosimetric impacts of motion artifacts, especially its interplay with the time-modulated dose delivery. Here four-dimensional (4d) robust optimization and dose repainting, which is the multiple application of the same field with reduced fluence, were combined. Two types of repainting were considered: layered and volumetric repainting. The time-resolved dose calculation, which is necessary to quantify the interplay effect, was integrated into the treatment planning system and validated. Nine clinical cases of hepatocellular carcinoma (HCC) showing motion in the range of 0.4–1.5 cm were studied. It was found that the repainted delivery of 4D robustly optimized plans reduced the impact of interplay effect as quantified by the homogeneity index within the clinical target volume (CTV) to a tolerable level. Similarly, the fractional over- and underdosage was reduced sufficiently for some HCC cases to achieve the purpose of motion management. This holds true for both investigated types of repainting with small dosimetric advantages of volume repainting over layered repainting. Volume repainting, however, cannot be applied clinically in proton centers with slow energy changes. Thus, it served as a reference in the in-silico evaluation. It is recommended to perform the dynamic dose calculation for individual cases to judge if robust optimization in conjunction with repainting is sufficient to keep the interplay effect within bounds.
format Online
Article
Text
id pubmed-9948857
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99488572023-02-23 Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma Siregar, Hilda Bäumer, Christian Blanck, Oliver Chan, Mark Engwall, Erik Plaude, Sandija Spaan, Bernhard Timmermann, Beate Wulff, Jörg Z Med Phys Original Paper Proton fields delivered by the active scanning technique can be interfered with the intrafractional motion. This in-silico study seeks to mitigate the dosimetric impacts of motion artifacts, especially its interplay with the time-modulated dose delivery. Here four-dimensional (4d) robust optimization and dose repainting, which is the multiple application of the same field with reduced fluence, were combined. Two types of repainting were considered: layered and volumetric repainting. The time-resolved dose calculation, which is necessary to quantify the interplay effect, was integrated into the treatment planning system and validated. Nine clinical cases of hepatocellular carcinoma (HCC) showing motion in the range of 0.4–1.5 cm were studied. It was found that the repainted delivery of 4D robustly optimized plans reduced the impact of interplay effect as quantified by the homogeneity index within the clinical target volume (CTV) to a tolerable level. Similarly, the fractional over- and underdosage was reduced sufficiently for some HCC cases to achieve the purpose of motion management. This holds true for both investigated types of repainting with small dosimetric advantages of volume repainting over layered repainting. Volume repainting, however, cannot be applied clinically in proton centers with slow energy changes. Thus, it served as a reference in the in-silico evaluation. It is recommended to perform the dynamic dose calculation for individual cases to judge if robust optimization in conjunction with repainting is sufficient to keep the interplay effect within bounds. Elsevier 2020-10-31 /pmc/articles/PMC9948857/ /pubmed/33131995 http://dx.doi.org/10.1016/j.zemedi.2020.08.001 Text en © 2021 The Author(s). Published by Elsevier GmbH on behalf of DGMP, ÖGMP and SSRMP. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Paper
Siregar, Hilda
Bäumer, Christian
Blanck, Oliver
Chan, Mark
Engwall, Erik
Plaude, Sandija
Spaan, Bernhard
Timmermann, Beate
Wulff, Jörg
Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma
title Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma
title_full Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma
title_fullStr Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma
title_full_unstemmed Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma
title_short Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma
title_sort mitigation of motion effects in pencil-beam scanning – impact of repainting on 4d robustly optimized proton treatment plans for hepatocellular carcinoma
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948857/
https://www.ncbi.nlm.nih.gov/pubmed/33131995
http://dx.doi.org/10.1016/j.zemedi.2020.08.001
work_keys_str_mv AT siregarhilda mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT baumerchristian mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT blanckoliver mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT chanmark mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT engwallerik mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT plaudesandija mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT spaanbernhard mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT timmermannbeate mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma
AT wulffjorg mitigationofmotioneffectsinpencilbeamscanningimpactofrepaintingon4drobustlyoptimizedprotontreatmentplansforhepatocellularcarcinoma